Display search results for ** instead (37 products)
18 Sep 2020  |  Global
Biosimilar Access to Newer Therapy Areas such as Ophthalmology to drive major growth of Biosimilar Market, 2020-2026
Outsourced manufacturing of complex third wave of biosimilars to spark new growth opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry highlighting the key growth opportunities, market revenue forecast and trends that will influence the industry with the third wave biosimilars. The global third wave biosimilars market covered in this study includes 2 major segments â...
USD 4,455.00 save 10 %
14 Sep 2020  |  North America
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...
10 Sep 2020  |  Europe
Rising EHR Adoption and ICD-10 Implementation Transforming the Computer Assisted Coding Market in Select European Countries, 2020
The Focus on Improving Documentation Efficiency and Achieving Maximum Reimbursement Drives Growth Opportunities
Clinical documentation using the electronic medical record (EMR) is the base for performing coding. Coding is predominantly done through manual work performed by a combination of coding/data management teams enabled by EMR, with few hospitals investing in specialized computer assisted coding (CAC) solutions. Majority of the hospitals are aware of t...
01 Sep 2020  |  North America
Future Growth Potential Lies in Precision Medicine andÂ Cloud Adoption in Oncology Care
As cancer care becomes increasingly highly complex, the information, image data, and steps that comprise a single patients healthcare journey has grown tremendously. Oncology information systems (OIS) software are used by cancer clinics and departments, medical oncologists, radiation specialists, and department employees to manage and plan the trea...
21 Aug 2020  |  Global
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivanâ€™s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new...
12 Aug 2020  |  North America
New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019â€“2025
AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities
Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...
12 Aug 2020  |  North America
Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth
The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...
24 Jul 2020  |  North America
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments â€“ antibody therapies,...
09 Jul 2020  |  North America
Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of â€˜Healthcare Preparednessâ€™
Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...
23 Jun 2020  |  North America
Data Interoperability is Key to Establish Connected Care
Background: Interoperability refers to the ability to exchange data among applications. In healthcare, this generally means the ability to share data between electronic health record (EHR) systems and other health IT applications such as clinical decision support (CDS), computerized physician order entry (CPOE) systems, and other systems in use in ...